Skip to main content
. 2018 Feb 14;13:957–973. doi: 10.2147/IJN.S152742

Table 1.

Specific concentrations of each sample used for viability experiments

DOXO (µM) TZ (µg mL−1) PLGA (µg mL−1)
DOXO 0.01, 0.1, 1, 5
PLGA-DOXO 0.01, 0.1, 1, 5 0.78, 7.8, 78, 390
PLGA-TZ-DOXO 0.01, 0.1, 1, 5 0.0236, 0.236, 2.36, 11.8 0.78, 7.8, 78, 390
TZ 0.0236, 0.236, 2.36, 11.8
PLGA-TZ 0.0236, 0.236, 2.36, 11.8 0.78, 7.8, 78, 390
PLGA 0.78, 7.8, 78, 390

Abbreviations: DOXO, doxorubicin hydrochloride; TZ, trastuzumab; PLGA, poly(lactic-co-glycolic) acid.